Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777331
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-13
First Post:
2021-02-26
Brief Title:
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinsons Disease
Sponsor:
Organization:
Hoffmann-La Roche